Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.53 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.53 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | DPP9 | Q86TI2 | 6/20 | 0.49 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.49 |
| ▸ | DPP4 | P27487 | 5/20 | 0.49 |
| ▸ | METAP1 | P53582 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.42 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3649449 | 1.00 | CA1 (0.59) | CA1CA2DPP7SLC15A1ZDHHC7 | |
| SCHEMBL186090 | 1.00 | CA1 (0.59) | CA1CA2DPP7SLC15A1ZDHHC7 | |
| Hydrochloric Acid SCHEMBL5192659 | 0.98 | CA1 (0.57) | CA1CA2DPP7SLC15A1ZDHHC7 | |
| Hydrochloric Acid SCHEMBL186088 | 0.98 | CA1 (0.57) | CA1CA2DPP7SLC15A1ZDHHC7 | |
| Hydrochloric Acid SCHEMBL186089 | 0.98 | CA1 (0.57) | CA1CA2DPP7SLC15A1ZDHHC7 | |
| SCHEMBL13295626 | 0.94 | ZDHHC7 (0.58) | CA1CA2DPP7SLC15A1ZDHHC7 | |
| SCHEMBL12041935 | 0.94 | ZDHHC7 (0.58) | CA1CA2DPP7SLC15A1ZDHHC7 | |
| SCHEMBL5192545 | 0.94 | ZDHHC7 (0.58) | CA1CA2DPP7SLC15A1ZDHHC7 | |
| SCHEMBL5477583 | 0.92 | ZDHHC7 (0.61) | CA1CA2DPP7SLC15A1ZDHHC7 | |
| SCHEMBL22551133 | 0.92 | ZDHHC7 (0.61) | CA1CA2DPP7SLC15A1ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | SOOCHOW UNIVERSITY (CN) | 2025-02-27 | — | — | US | claimed |
| CN-116836219-A | Synthesis of novel corosolic acid derivatives and their use in insulin resistance and anti-inflammatory therapy | 苏州大学 | 2023-10-03 | — | — | CN | claimed |
| CN-115477681-A | Pentacyclic triterpenoid saponin derivative and preparation method and application thereof | 苏州大学 | 2022-12-16 | — | — | CN | claimed |
| CN-108976147-B | Amino n-hexanoyl amido methyl-n-hexanoyl basic amino acid, synthesis, activity and application thereof | 首都医科大学 | 2021-02-12 | — | — | CN | claimed |
| CN-109081790-B | Amino n-hexanoyl amido methyl-n-hexanoyl basic amino acid, synthesis, activity and application thereof | 首都医科大学 | 2021-02-12 | — | — | CN | claimed |
| CN-108976145-B | Amino n-hexanoyl amido methyl-acylamino n-hexanoyl polar amino acid, synthesis, activity and application thereof | 首都医科大学 | 2020-12-01 | — | — | CN | claimed |
| CN-108947978-B | 3R-indolylmethyl-6R-Tyr modified piperazine-2, 5-diketone and synthesis, activity and application thereof | 首都医科大学 | 2020-12-01 | — | — | CN | claimed |
| CN-108976146-B | Amino n-hexanoyl methyl cyclamido n-hexanoyl aromatic amino acid, synthesis, activity and application thereof | 首都医科大学 | 2020-11-27 | — | — | CN | claimed |
| CN-109456311-A | Piperazine -2,5- diketone of 3R- indole methyl -6R- ArAA modification, synthesis, activity and application | 首都医科大学 | 2019-03-12 | — | — | CN | claimed |
| CN-109134328-A | The positive positive hexanoyl Met of hexanoyl first cyclic amide base of amino, synthesis, activity and application | 首都医科大学 | 2019-01-04 | — | — | CN | claimed |
| CN-108947981-A | Piperazine -2,5- diketone of 3R- indole methyl -6S- fatty acid/amino acid modification, synthesis, activity and application | 首都医科大学 | 2018-12-07 | — | — | CN | claimed |
| CN-108947979-A | Piperazine -2,5- diketone of 3R- indole methyl -6R- polar amino acid modification, synthesis, activity and application | 首都医科大学 | 2018-12-07 | — | — | CN | claimed |
| CN-108948141-A | Piperazine -2,5- diketone of 3R- indole methyl -6S-Pro modification, synthesis, activity and application | 首都医科大学 | 2018-12-07 | — | — | CN | claimed |
| CN-108947977-A | Piperazine -2,5- diketone of 3R- indole methyl -6R- amide side chains amino acid modification, synthesis, activity and application | 首都医科大学 | 2018-12-07 | — | — | CN | claimed |
| CN-108947978-A | Piperazine -2,5- diketone of 3R- indole methyl -6R-Tyr modification, synthesis, activity and application | 首都医科大学 | 2018-12-07 | — | — | CN | claimed |
| CN-108929369-A | Piperazine -2,5- diketone of 3R- indole methyl -6R- acidic amino acid modification, synthesis, activity and application | 首都医科大学 | 2018-12-04 | — | — | CN | claimed |
| CN-108929315-A | Piperazine -2,5- diketone of 3R- indole methyl -6S- methionine modification, synthesis, activity and application | 首都医科大学 | 2018-12-04 | — | — | CN | claimed |
| CN-108929313-A | Piperazine -2,5- diketone of 3R- indole methyl -6R- fatty acid/amino acid modification, synthesis, activity and application | 首都医科大学 | 2018-12-04 | — | — | CN | claimed |
| CN-108929320-A | Piperazine -2,5- diketone of 3R- indole methyl -6R- oxazolidone modification, synthesis, activity and application | 首都医科大学 | 2018-12-04 | — | — | CN | claimed |
| US-20070161633-A1 | 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases | ELAN PHARMACEUTICALS, INC. (US) | 2007-07-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070161633-A1 | 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases | BDKRB1, BDKRB2, HRH2 | CA1 2900/4885CA2 2315/4885DPP7 3440/4885 |
| US-20250066409-A1 | DERIVATIVE OF PENTACYCLIC TRITERPENOIDAL SAPONIN AND ITS PREPARATION METHOD AND APPLICATION | CASP4, CASP3, CASP14 | CA1 878/4885CA2 2646/4885DPP7 3254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.